These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2099 related articles for article (PubMed ID: 33219837)

  • 1. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
    Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
    Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
    Zhang QY; Xu BW; Du JB
    World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
    Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A;
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
    Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
    Front Immunol; 2021; 12():632890. PubMed ID: 33732254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
    Cherqaoui B; Koné-Paut I; Yager H; Bourgeois FL; Piram M
    Rheumatology (Oxford); 2021 Oct; 60(10):4530-4537. PubMed ID: 33493353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features.
    Rowley AH
    J Pediatr; 2020 Sep; 224():129-132. PubMed ID: 32585239
    [No Abstract]   [Full Text] [Related]  

  • 7. Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.
    Bukulmez H
    Curr Rheumatol Rep; 2021 Jul; 23(8):58. PubMed ID: 34216296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children mimicking Kawasaki disease.
    Mercier JC; Ouldali N; Melki I; Basmaci R; Levy M; Titomanlio L; Beyler C; Meinzer U
    Arch Cardiovasc Dis; 2021 May; 114(5):426-433. PubMed ID: 34052147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.
    Marzano AV; Cassano N; Moltrasio C; Verdoni L; Genovese G; Vena GA
    Dermatology; 2022; 238(1):35-43. PubMed ID: 34062530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2.
    Henderson LA; Canna SW; Friedman KG; Gorelik M; Lapidus SK; Bassiri H; Behrens EM; Ferris A; Kernan KF; Schulert GS; Seo P; Son MBF; Tremoulet AH; Yeung RSM; Mudano AS; Turner AS; Karp DR; Mehta JJ
    Arthritis Rheumatol; 2021 Apr; 73(4):e13-e29. PubMed ID: 33277976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of early characteristics of multisystemic inflammatory syndrome and Kawasaki disease in children and the course of Kawasaki disease in the pandemic.
    Alkan F; Bircan O; Bal A; Bayturan S; Zengin N; Coskun S
    BMC Pediatr; 2024 Jul; 24(1):485. PubMed ID: 39080588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multisystem Inflammatory Syndrome in Children (MIS-C).
    Patel JM
    Curr Allergy Asthma Rep; 2022 May; 22(5):53-60. PubMed ID: 35314921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2.
    Yeo WS; Ng QX
    Med Hypotheses; 2020 Nov; 144():110263. PubMed ID: 33254568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases.
    Noval Rivas M; Arditi M
    Rheum Dis Clin North Am; 2023 Aug; 49(3):647-659. PubMed ID: 37331738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist.
    Papadopoulou C; Al Obaidi M; Moraitis E; Compeyrot-Lacassagne S; Eleftheriou D; Brogan P
    Rheumatology (Oxford); 2021 Feb; 60(2):911-917. PubMed ID: 33197261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
    Whittaker E; Bamford A; Kenny J; Kaforou M; Jones CE; Shah P; Ramnarayan P; Fraisse A; Miller O; Davies P; Kucera F; Brierley J; McDougall M; Carter M; Tremoulet A; Shimizu C; Herberg J; Burns JC; Lyall H; Levin M;
    JAMA; 2020 Jul; 324(3):259-269. PubMed ID: 32511692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.
    Lee PY; Day-Lewis M; Henderson LA; Friedman KG; Lo J; Roberts JE; Lo MS; Platt CD; Chou J; Hoyt KJ; Baker AL; Banzon TM; Chang MH; Cohen E; de Ferranti SD; Dionne A; Habiballah S; Halyabar O; Hausmann JS; Hazen MM; Janssen E; Meidan E; Nelson RW; Nguyen AA; Sundel RP; Dedeoglu F; Nigrovic PA; Newburger JW; Son MBF
    J Clin Invest; 2020 Nov; 130(11):5942-5950. PubMed ID: 32701511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
    Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 in children: Pathogenesis and current status.
    Frenkel LD; Gomez F; Bellanti JA
    Allergy Asthma Proc; 2021 Jan; 42(1):8-15. PubMed ID: 33404385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 105.